Prostate Cancer Survival and the Importance of Dre and Psa Testing

Prostate cancer survival depends on the stage in which the patient is diagnosed to have the cancer and also upon other factors like his race, his family cancer history, and his life style and dietary habits. The age at which the cancer strikes the patient, by and large mostly determines prostate cancer life expectancy.

The early stage recognition of cancer in the patient’s body is always considered advantageous in preventing its spreading to other parts of his body. This phenomenon called metastasis negates the effects of the treatments and makes his survival uncertain. Health officials are of the view that doing biopsy tests to patients above 70 is counter-productive and might impinge on their prostate cancer life expectancy.

In general, the diagnostic skills measure the chances of prostate cancer survival. Diagnosis is conducted by two methods – staging and grading. Four successive stages have been recognized about the severity of the malaise. When the cancer is confined within the prostate, it is Stage A. Stage B denotes there are numerous cell clusters – nodules – have started forming but still confined to the prostate area. Stage C represents modules spreading locally. Stage D is the final stage when modules get transported to all parts of the body triggering metastasis.

Gleason scaling system evaluates the progress of prostate cancer. It has evolved a scale for measurement of the spreading of prostate cancer. The scales used are from 2 to 10. Up to 6 in the scale, the cancer cells are not multiplying and the chance of spreading is slim. A scale of 7 indicated aggressive cell formation and all Gleason scales from 8 to 10 pinpoints metastasis.

Prevention is better than cure is a good proverbial statement but it is not true to prostate cancer unfortunately. There are no known methods to prevent the onset of cancer but to reduce the intensity of the risk, researches point to specified diets and lifeline choices. Exercising in the fresh air full of oxygen and eating a low-fat diet will go a long ay to mitigate the risk.

Different treatment options are being conducted to prolong prostate cancer life expectancy. But, according to Medical Review Boards, it takes minimum 10 years to complete detailed studies on vast population sampling and it is thus a costly proposition. Hence they had to borrow data taken from old files, which, naturally, is not at all viable.

Old men around 70 present another difficult pattern. As the prostate cancer is a very slow growing one, those elderly men’s chances of succumbing to other ailments become a distinct possibility. Hence, slow growing prostate cancer might not be a big threat to them at all.

Prostate cancer survival is an intricate issue. The triggering of cancer mechanism is governed by multiple factors like food habits, and lifestyle. Prostate cancer life expectancy, on the other hand, is dictated by the treatment options and the age.